Identification of EGF as an Important Regulator for Promoting CYP3A4 Expression in Human Embryonic Stem Cell-Derived Hepatocytes Using TALEN-Based Gene Targeting

Ming Yin; Huan Yang; Xiaohua Su; Ziyi Li; Zhanpeng Yue; Xueming Zhang; Da Sun; Yan Shi; Dexue Li

doi:10.1016/j.jgg.2014.03.008

Volume 41 Issue 6

Jun. 2014

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2014 > 41(6): 349-352

PDF( 1201 KB)

Identification of EGF as an Important Regulator for Promoting CYP3A4 Expression in Human Embryonic Stem Cell-Derived Hepatocytes Using TALEN-Based Gene Targeting

doi: 10.1016/j.jgg.2014.03.008

a
College of Veterinary Medicine, Jilin University, Changchun 130062, China
b
Shenzhen Stem Cell Engineering Laboratory, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen 518055, China
c
Academy of Military Medical Sciences, Beijing 100871, China

More Information

Corresponding author: E-mail address: shiyan@pkusz.edu.cn (Yan Shi); E-mail address: lidx@bmi.ac.cn (Dexue Li)
Received Date: 2013-12-02
Accepted Date: 2014-03-28
Rev Recd Date: 2014-03-28

Available Online: 2014-04-12

Publish Date: 2014-06-20

Abstract

FullText(HTML)

References(17)

References

[1]	Bombail, V., Taylor, K., Gibson, G.G. et al. Drug Metab. Dispos., 32 (2004),pp. 525-535
[2]	Borowiak, M., Garratt, A.N., Wustefeld, T. et al. Met provides essential signals for liver regeneration Proc. Natl. Acad. Sci. USA, 101 (2004),pp. 10608-10613
[3]	Carver, R.S., Stevenson, M.C., Scheving, L.A. et al. Diverse expression of ErbB receptor proteins during rat liver development and regeneration Gastroenterology, 123 (2002),pp. 2017-2027
[4]	Collin de L'hortet, A., Gilgenkrantz, H., Guidotti, J.E. EGFR: a master piece in G1/S phase transition of liver regeneration Int. J. Hepatol., 2012 (2012)
[5]	de Sa Silva, F., Almeida, P.N., Rettore, J.V. et al. Toward personalized cell therapies by using stem cells: seven relevant topics for safety and success in stem cell therapy J. Biomed. Biotechnol., 2012 (2012)
[6]	Dianat, N., Steichen, C., Vallier, L. et al. Human pluripotent stem cells for modelling human liver diseases and cell therapy Curr. Gene Ther., 13 (2013),pp. 120-132
[7]	Godoy, P., Hewitt, N.J., Albrecht, U. et al. Arch. Toxicol., 87 (2013),pp. 1315-1530
[8]	Haigh, J.J. Role of VEGF in organogenesis Organogenesis, 4 (2008),pp. 247-256
[9]	Hines, R.N. Ontogeny of human hepatic cytochromes P450 J. Biochem. Mol. Toxicol., 21 (2007),pp. 169-175
[10]	Hockemeyer, D., Wang, H., Kiani, S. et al. Genetic engineering of human pluripotent cells using TALE nucleases Nat. Biotechnol., 29 (2011),pp. 731-734
[11]	Klein, K., Zanger, U.M. Pharmacogenomics of cytochrome P450 3A4: recent progress toward the “missing heritability” problem Front. Genet., 4 (2013),p. 12
[12]	Sahi, J., Grepper, S., Smith, C. Hepatocytes as a tool in drug metabolism, transport and safety evaluations in drug discovery Curr. Drug Discov. Technol., 7 (2010),pp. 188-198
[13]	Shifley, E.T., Kenny, A.P., Rankin, S.A. et al. BMC Dev. Biol., 12 (2012),p. 27
[14]	Tong, C., Huang, G., Ashton, C. et al. Rapid and cost-effective gene targeting in rat embryonic stem cells by TALENs J. Genet. Genomics, 39 (2012),pp. 275-280
[15]	Tsai, S.M., Liu, D.W., Wang, W.P. Fibroblast growth factor (Fgf) signaling pathway regulates liver homeostasis in zebrafish Transgenic Res., 22 (2013),pp. 301-314
[16]	Zanger, U.M., Schwab, M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation Pharmacol. Ther., 138 (2013),pp. 103-141
[17]	Zhao, D., Chen, S., Duo, S. et al. Promotion of the efficient metabolic maturation of human pluripotent stem cell-derived hepatocytes by correcting specification defects Cell Res., 23 (2013),pp. 157-161